(Q45215341)

10 December 2017

Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands (English)

1 reference

10 December 2017

0 references

1 reference

1 reference

1 reference

A A van Zwet

1

1 reference

10 December 2017

W A de Boer

2

1 reference

10 December 2017

P M Schneeberger

3

1 reference

10 December 2017

J Weel

4

1 reference

10 December 2017

A R Jansz

5

1 reference

10 December 2017

J C Thijs

6

1 reference

10 December 2017

1 November 1996

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

10 December 2017

1 reference

10 December 2017

15

1 reference

10 December 2017

11

1 reference

10 December 2017

861-864

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01691216

10 December 2017

0 references

cites work

Role of metronidazole resistance in therapy of Helicobacter pylori infections

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01691216

In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01691216

Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease

21 January 2018

1 reference

12 December 2020

Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.

1 reference

12 December 2020

The E test for antimicrobial susceptibility testing of Helicobacter pylori.

1 reference

12 December 2020

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial

1 reference

12 December 2020

Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.

1 reference

12 December 2020

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

1 reference

12 December 2020

Practical diagnosis of Helicobacter pylori infection.

1 reference

12 December 2020

In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment or microbiologists' obsession?

1 reference

12 December 2020

A reliable cure for Helicobacter pylori infection?

1 reference

12 December 2020

Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

1 reference

12 December 2020

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies

1 reference

12 December 2020

The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?

1 reference

12 December 2020

Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori

1 reference

12 December 2020

Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia.

1 reference

12 December 2020

Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

1 reference

12 December 2020

Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori

1 reference

12 December 2020

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

12 December 2020

Treatment of Helicobacter pylori infections.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01691216

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference